Drug class
Substituted benzamide; dopamine D2/D3 receptor antagonist with prokinetic and antipsychotic activity
Mechanism of action
Blocks dopamine D2-family receptors centrally and in the enteric nervous system. Peripheral D2 blockade in the myenteric and submucosal plexuses enhances cholinergic activity and gastrointestinal motility; central dopaminergic blockade contributes to its antipsychotic and antiemetic pharmacology.
General use cases
- Symptomatic treatment of functional dyspepsia and selected upper gastrointestinal motility disorders where authorised.
- Psychiatric use for selected psychotic disorders is product- and jurisdiction-specific.
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
